{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:09:52Z","timestamp":1793642992047,"version":"4.5.1"},"reference-count":154,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["COV0176"],"award-info":[{"award-number":["COV0176"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,4,29]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Community pharmacists and their teams have remained accessible to the public providing essential services despite immense pressures during the COVID-19 pandemic. They have successfully expanded the influenza vaccination programme and are now supporting the delivery of the COVID-19 vaccination roll-out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This rapid realist review aims to understand how community pharmacy can most effectively deliver essential and advanced services, with a focus on vaccination, during the pandemic and in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>An embryonic programme theory was generated using four diverse and complementary documents along with the expertise of the project team. Academic databases, preprint services and grey literature were searched and screened for documents meeting our inclusion criteria. The data were extracted from 103 documents to develop and refine a programme theory using a realist logic of analysis. Our analysis generated 13 context-mechanism-outcome configurations explaining when, why and how community pharmacy can support public health vaccination campaigns, maintain essential services during pandemics and capitalise on opportunities for expanded, sustainable public health service roles. The views of stakeholders including pharmacy users, pharmacists, pharmacy teams and other healthcare professionals were sought throughout to refine the 13 explanatory configurations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 13 context-mechanism-outcome configurations are organised according to decision makers, community pharmacy teams and community pharmacy users as key actors. Review findings include: supporting a clear role for community pharmacies in public health; clarifying pharmacists\u2019 legal and professional liabilities; involving pharmacy teams in service specification design; providing suitable guidance, adequate compensation and resources; and leveraging accessible, convenient locations of community pharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Community pharmacy has been able to offer key services during the pandemic. Decision makers must endorse, articulate and support a clear public health role for community pharmacy. We provide key recommendations for decision makers to optimise such a role during these unprecedented times and in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-050043","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T20:40:38Z","timestamp":1623876038000},"page":"e050043","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":75,"title":["Rapid realist review of the role of community pharmacy in the public health response to COVID-19"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4152-9704","authenticated-orcid":false,"given":"Ian","family":"Maidment","sequence":"first","affiliation":[{"name":"College of Health and Life Sciences, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Young","sequence":"additional","affiliation":[{"name":"The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"MacPhee","sequence":"additional","affiliation":[{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Booth","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Zaman","sequence":"additional","affiliation":[{"name":"University of Bradford, Bradford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Breen","sequence":"additional","affiliation":[{"name":"College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hilton","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Hull, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Kelly","sequence":"additional","affiliation":[{"name":"NHS Birmingham and Solihull Clinical Commissioning Group, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Wong","sequence":"additional","affiliation":[{"name":"Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"2025121510063367000_11.6.e050043.1","doi-asserted-by":"publisher","DOI":"10.1177\/2374373520927638"},{"key":"2025121510063367000_11.6.e050043.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-020-01568-x","article-title":"Towards an understanding of the burdens of medication management affecting older people: the memorable realist synthesis","volume":"20","author":"Maidment","year":"2020","journal-title":"BMC Geriatr"},{"key":"2025121510063367000_11.6.e050043.3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11096-020-01116-y","article-title":"Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia","volume":"43","author":"Barry","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2025121510063367000_11.6.e050043.4","doi-asserted-by":"crossref","unstructured":"Wickware C . Pharmacies\u2019 dispensing increases by up to a third as a result of COVID-19, survey finds. Pharm J 2020.doi:10.1211\/PJ.2020.20207917","DOI":"10.1211\/PJ.2020.20207917"},{"key":"2025121510063367000_11.6.e050043.5","unstructured":"Pharmaceutical Services Negotiating Committee . Flu vaccination service, 2020. Available: https:\/\/psnc.org.uk\/services-commissioning\/advanced-services\/flu-vaccination-service"},{"key":"2025121510063367000_11.6.e050043.6","unstructured":"Pharmaceutical Services Negotiating Committee . Vaccination services, 2020. Available: https:\/\/psnc.org.uk\/services-commissioning\/locally-commissioned-services\/vaccination-services"},{"key":"2025121510063367000_11.6.e050043.7","doi-asserted-by":"crossref","unstructured":"Rendell T . Community pharmacist-led influenza vaccination: a service evaluation. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208383","DOI":"10.1211\/PJ.2020.20208383"},{"key":"2025121510063367000_11.6.e050043.8","unstructured":"Public Health England . Beyond the data: understanding the impact of COVID-19 on BamE groups. London: Public Health England, 2020. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/892376\/COVID_stakeholder_engagement_synthesis_beyond_the_data.pdf"},{"key":"2025121510063367000_11.6.e050043.9","doi-asserted-by":"crossref","unstructured":"Patel M . We must tear down the barriers to equality for BamE communities highlighted by COVID-19. Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208060","DOI":"10.1211\/PJ.2020.20208060"},{"key":"2025121510063367000_11.6.e050043.10","doi-asserted-by":"crossref","unstructured":"Robinson J . Ten things pharmacists should know about COVID-19 vaccines. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2021.20208429","DOI":"10.1097\/01.NT.0000732768.21297.fe"},{"key":"2025121510063367000_11.6.e050043.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009059"},{"key":"2025121510063367000_11.6.e050043.12","doi-asserted-by":"crossref","unstructured":"Maidment ID , Lawson S , Wong G . Health services and delivery research. medication management in older people: the memorable realist synthesis. Southampton (UK: NIHR Journals Library, 2020.","DOI":"10.3310\/hsdr08260"},{"key":"2025121510063367000_11.6.e050043.13","doi-asserted-by":"crossref","unstructured":"Maidment I , Young E , Wong G . A rapid realist review of community pharmacy support for the public health agenda during the COVID-19 pandemic and future health emergencies. PROSPERO 2020:CRD42020194078.","DOI":"10.1101\/2021.02.01.21250765"},{"key":"2025121510063367000_11.6.e050043.14","doi-asserted-by":"publisher","DOI":"10.3310\/hsdr02300"},{"key":"2025121510063367000_11.6.e050043.15","doi-asserted-by":"crossref","unstructured":"Pharmacies across the UK close 'intermittently' to cope with increasing pressures from COVID-19. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20207844","DOI":"10.1211\/PJ.2020.20207844"},{"key":"2025121510063367000_11.6.e050043.16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.sapharm.2020.03.015","article-title":"On the frontline against COVID-19: community pharmacists' contribution during a public health crisis","volume":"17","author":"Cadogan","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.17","unstructured":"Royal Pharmaceutical Society . Rps guidance on ethical, professional decision making in the COVID-19 pandemic. London: Royal Pharmaceutical Society, 2020. https:\/\/www.rpharms.com\/resources\/pharmacy-guides\/coronavirus-covid-19\/coronavirus-information-for-pharmacists\/ethical-decision-making"},{"key":"2025121510063367000_11.6.e050043.18","unstructured":"Pharmaceutical Services Negotiating Committee . PSNC briefing 023\/20: early guidance on the 2020\/21 seasonal influenza vaccination advanced service, 2020. Available: https:\/\/psnc.org.uk\/services-commissioning\/psnc-briefings-services-and-commissioning\/psnc-briefing-023-20-early-guidance-on-the-2020-21-seasonal-influenza-vaccination-advanced-service"},{"key":"2025121510063367000_11.6.e050043.19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.sapharm.2019.06.015","article-title":"Successful implementation and provision of enhanced and extended pharmacy services","volume":"16","author":"Hattingh","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.20","unstructured":"Greenhalgh T , Wong G , Westhorp G . Retroduction in realist evaluation. The RAMESES project, 2017. Available: http:\/\/www.ramesesproject.org\/media\/RAMESES_II_Retroduction.pdf"},{"key":"2025121510063367000_11.6.e050043.21","doi-asserted-by":"crossref","unstructured":"Wong G . Data gathering in realist reviews: looking for needles in haystacks. doing realist research. Thousand Oaks: SAGE Publications Ltd, 2018: 131\u201346.","DOI":"10.4135\/9781526451729.n9"},{"key":"2025121510063367000_11.6.e050043.22","doi-asserted-by":"crossref","unstructured":"Long N . Development sociology: actor perspectives. London: Routledge, 2003.","DOI":"10.4324\/9780203398531"},{"key":"2025121510063367000_11.6.e050043.23","doi-asserted-by":"crossref","unstructured":"Strand MA , Bratberg J , Eukel H , et al . Community pharmacists\u2019 contributions to disease management during the COVID-19 pandemic. Prev Chronic Dis 2020;17.doi:10.5888\/pcd17.200317","DOI":"10.5888\/pcd17.200317"},{"key":"2025121510063367000_11.6.e050043.24","doi-asserted-by":"publisher","DOI":"10.1177\/1715163520945741"},{"key":"2025121510063367000_11.6.e050043.25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.sapharm.2020.02.003","article-title":"Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak","volume":"16","author":"Ung","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.26","doi-asserted-by":"crossref","unstructured":"Elbeddini A , Prabaharan T , Almasalkhi S , et al . Pharmacists and COVID-19. J Pharm Policy Pract 2020;13.doi:10.1186\/s40545-020-00241-3","DOI":"10.1186\/s40545-020-00241-3"},{"key":"2025121510063367000_11.6.e050043.27","unstructured":"National Pharmacy Association . Public see pharmacies as key to the future of healthcare in wake of pandemic, 2020. Available: https:\/\/www.npa.co.uk\/news-and-events\/news-item\/public-see-pharmacies-as-key-to-the-future-of-healthcare-in-wake-of-pandemic"},{"key":"2025121510063367000_11.6.e050043.28","doi-asserted-by":"crossref","unstructured":"Wickware C . NHS England to choose \u2019selected' number of pharmacies to deliver at least 1,000 COVID-19 vaccines per week. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208608","DOI":"10.1211\/PJ.2020.20208608"},{"key":"2025121510063367000_11.6.e050043.29","unstructured":"Pharmaceutical Services Negotiating Committee . Community pharmacy contractual framework: pharmaceutical services negotiating Committee, 2021. Available: https:\/\/psnc.org.uk\/contract-it\/the-pharmacy-contract"},{"key":"2025121510063367000_11.6.e050043.30","unstructured":"Royal Pharmaceutical Society . All-Party pharmacy group warns of pressures on pharmacies. London: Royal Pharmaceutical Society, 2020. https:\/\/www.rpharms.com\/about-us\/news\/details\/All-Party-Pharmacy-Group-warns-of-pressures-on-pharmacies#:~:text=The%20All%2DParty%20Pharmacy%20Group,continued%20pressures%20facing%20community%20pharmacies"},{"key":"2025121510063367000_11.6.e050043.31","unstructured":"NHS England and NHS Improvement coronavirus . Urgent preparing for community pharmacy to contribute to a potential COVID-19 vaccination programme. In: Service NH, ed. London: NHS England and NHS Improvement coronavirus, 2020. https:\/\/www.england.nhs.uk\/coronavirus\/covid-19-vaccination-programme\/primary-care-guidance\/preparing-for-community-pharmacy-to-contribute-to-a-potential-covid-19-vaccination-programme"},{"key":"2025121510063367000_11.6.e050043.32","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X684349"},{"key":"2025121510063367000_11.6.e050043.33","unstructured":"Stewart K , Barai R , Priarities N . How to keep your community pharmacy running during the COVID-19 pandemic, 2020. Available: https:\/\/pharmaceutical-journal.com\/article\/ld\/how-to-keep-your-community-pharmacy-running-during-the-covid-19-pandemic"},{"key":"2025121510063367000_11.6.e050043.34","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.sapharm.2020.07.015","article-title":"Drive-thru pharmacy services: a way forward to combat COVID-19 pandemic","volume":"17","author":"Hussain","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.35","doi-asserted-by":"crossref","unstructured":"Elbeddini A , Wen CX , Tayefehchamani Y , et al . Mental health issues impacting pharmacists during COVID-19. J Pharm Policy Pract 2020;13.doi:10.1186\/s40545-020-00252-0","DOI":"10.1186\/s40545-020-00252-0"},{"key":"2025121510063367000_11.6.e050043.36","unstructured":"Quinn B . UK pharmacists facing abuse and violence during lockdown. The Guardian, 2020. Available: https:\/\/www.theguardian.com\/world\/2020\/apr\/02\/uk-pharmacists-facing-abuse-and-violence-during-coronavirus-lockdown"},{"key":"2025121510063367000_11.6.e050043.37","unstructured":"NHS England and NHS Improvement coronavirus . Urgent preparing for general practice to contribute to a potential COVID-19 vaccination programme. service NH ED. London: NHS England and NHS Improvement coronavirus, 2020. https:\/\/www.england.nhs.uk\/coronavirus\/covid-19-vaccination-programme\/primary-care-guidance\/preparing-for-gp-to-contribute-to-a-potential-covid-19-vaccination-programme"},{"key":"2025121510063367000_11.6.e050043.38","doi-asserted-by":"crossref","unstructured":"Wickware C . Health board pilots delivery of flu vaccines by pharmacy technicians to manage increased demand. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208565","DOI":"10.1211\/PJ.2020.20208565"},{"key":"2025121510063367000_11.6.e050043.39","unstructured":"Royal Pharmaceutical Society . The future of pharmacy in a sustainable NHS: key principles for transformation and growth. London: Royal Pharmaceutical Society, 2020. https:\/\/www.rpharms.com\/recognition\/all-our-campaigns\/policy-a-z\/future-of-pharmacy"},{"key":"2025121510063367000_11.6.e050043.40","doi-asserted-by":"crossref","unstructured":"Moore A . No going back: how the pandemic is changing community pharmacy. The Pharmaceutical Journal 2020;305.doi:10.1211\/PJ.2020.20208309","DOI":"10.1211\/PJ.2020.20208309"},{"key":"2025121510063367000_11.6.e050043.41","doi-asserted-by":"publisher","DOI":"10.12968\/prma.2021.31.1.20"},{"key":"2025121510063367000_11.6.e050043.42","doi-asserted-by":"crossref","first-page":"153-155","DOI":"10.1111\/jrh.12439","article-title":"COVID-19: how can rural community pharmacies respond to the outbreak?","volume":"37","author":"Adunlin","year":"2021","journal-title":"J Rural Health"},{"key":"2025121510063367000_11.6.e050043.43","unstructured":"Fiore V . GP referrals under CPCS to go live November 1, NHSE confirms. Chemist and Druggist, 2020. Available: https:\/\/www.chemistanddruggist.co.uk\/news\/-gp-referrals-under-cpcs-live-november-1-nhse-says"},{"key":"2025121510063367000_11.6.e050043.44","doi-asserted-by":"crossref","unstructured":"Robinson J . Government consults on allowing pharmacy technicians to administer COVID-19 and flu vaccines. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208311","DOI":"10.1211\/PJ.2020.20208311"},{"key":"2025121510063367000_11.6.e050043.45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.sapharm.2012.05.006","article-title":"How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives","volume":"10","author":"Saramunee","year":"2014","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.sapharm.2006.09.001","article-title":"Pharmacy practice in times of civil crisis: The experience of SARS and \u201cthe blackout\u201d in Ontario, Canada","volume":"3","author":"Austin","year":"2007","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"2025121510063367000_11.6.e050043.47","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2016.172"},{"key":"2025121510063367000_11.6.e050043.48","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2013.99"},{"key":"2025121510063367000_11.6.e050043.49","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2017.1"},{"key":"2025121510063367000_11.6.e050043.50","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20160135"},{"key":"2025121510063367000_11.6.e050043.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2015.02.007"},{"key":"2025121510063367000_11.6.e050043.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2013.04.003"},{"key":"2025121510063367000_11.6.e050043.53","unstructured":"OECD . Beyond containment: health systems responses to COVID-19 in the OECD. organisation for economic co-operation and development, Paris, 2020. Available: https:\/\/read.oecd-ilibrary.org\/view\/?ref=119_119689-ud5comtf84&title=Beyond_Containment:Health_systems_responses_to_COVID-19_in_the_OECD"},{"key":"2025121510063367000_11.6.e050043.54","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0912-0"},{"key":"2025121510063367000_11.6.e050043.55","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.sapharm.2020.06.014","article-title":"Community pharmacy response to infection control during COVID-19. A cross-sectional survey","volume":"17","author":"Sum","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.56","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17020536","article-title":"The community pharmacist: perceived barriers and patient-centered care communication","volume":"17","author":"Ilardo","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025121510063367000_11.6.e050043.57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/pharmacy8030172","article-title":"Community pharmacists\u2019 perceptions of patient care services within an enhanced service network","volume":"8","author":"Daly","year":"2020","journal-title":"Pharmacy"},{"key":"2025121510063367000_11.6.e050043.58","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-8044-y","article-title":"Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting","volume":"19","author":"Ecarnot","year":"2019","journal-title":"BMC Public Health"},{"key":"2025121510063367000_11.6.e050043.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2013.02.005"},{"key":"2025121510063367000_11.6.e050043.60","unstructured":"NHS England . General practice forward view: NHS England, 2016. [Available from. Available: https:\/\/www.england.nhs.uk\/gp\/gpfv. Accessed 12\/12\/20"},{"key":"2025121510063367000_11.6.e050043.61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/hex.12639","article-title":"Patient and public perspectives of community pharmacies in the United Kingdom: a systematic review","volume":"21","author":"Hindi","year":"2018","journal-title":"Health Expectations"},{"key":"2025121510063367000_11.6.e050043.62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/hsc.12618","article-title":"Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK","volume":"27","author":"Hindi","year":"2019","journal-title":"Health Soc Care Community"},{"key":"2025121510063367000_11.6.e050043.63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/ijpp.12462","article-title":"Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: a systematic review","volume":"26","author":"Milosavljevic","year":"2018","journal-title":"Int J Pharm Pract"},{"key":"2025121510063367000_11.6.e050043.64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220658"},{"key":"2025121510063367000_11.6.e050043.65","unstructured":"Pharmaceutical Services Negotiating Committee . Preparations for a potential COVID-19 vaccination programme: pharmaceutical services negotiating Committee, 2020. Available: https:\/\/psnc.org.uk\/our-news\/preparations-for-a-potential-covid-19-vaccination-programme"},{"key":"2025121510063367000_11.6.e050043.66","unstructured":"Royal Pharmaceutical Society . RPS statement on the role of pharmacists in the COVID-19 vaccination programme. London: Royal Pharmaceutical Society, 2020. https:\/\/www.rpharms.com\/Portals\/0\/FINAL_Statement%20on%20COVID-19%20Vaccination_Dec%202020_.pdf?ver=2020-12-02-143304-017"},{"key":"2025121510063367000_11.6.e050043.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2016.08.006"},{"key":"2025121510063367000_11.6.e050043.68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.sapharm.2019.06.016","article-title":"Community pharmacists at the heart of public health: a longitudinal evaluation of the community pharmacy influenza vaccination service","volume":"16","author":"Deslandes","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.69","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.sapharm.2020.07.004","article-title":"FIP\u2019s response to the COVID-19 pandemic: Global pharmacy rises to the challenge","volume":"17","author":"Sousa Pinto","year":"2021","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"2025121510063367000_11.6.e050043.70","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1080\/21645515.2016.1215393","article-title":"Community pharmacies as sites of adult vaccination: a systematic review","volume":"12","author":"Burson","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2025121510063367000_11.6.e050043.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.05.021"},{"key":"2025121510063367000_11.6.e050043.72","unstructured":"Francis M , Hinchliffe A , Wales N . Vaccination services through community pharmacy. public health Wales NHS trust, Wales: NHS Wales, 2010. Available: http:\/\/www2.nphs.wales.nhs.uk:8080\/HealthServiceQDTDocs.nsf\/public\/CBDDC3C0BE9449398025793B00341A6F\/$file\/Vaccination%20services%20through%20community%20pharmacy%20v1a.pdf"},{"key":"2025121510063367000_11.6.e050043.73","doi-asserted-by":"crossref","unstructured":"Clews G . Pharmacists able to administer unlicensed COVID-19 vaccines following legislation changes. The Pharmaceutical Journal 2020;305.doi:10.1211\/PJ.2020.20208453","DOI":"10.1211\/PJ.2020.20208453"},{"key":"2025121510063367000_11.6.e050043.74","unstructured":"Welsh Government, Department of Health N. I, Scottish Government . Supporting pharmacists, pharmacy technicians and pharmacy teams throughout the second COVID-19 wave, 2020. Available: https:\/\/www.pharmacyregulation.org\/news\/joint-letter-supporting-pharmacy-professionals-and-teams-through-second-covid-19-wave"},{"key":"2025121510063367000_11.6.e050043.75","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3757"},{"key":"2025121510063367000_11.6.e050043.76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/ijpp.12635","article-title":"Pestle and mortal: the demise of community pharmacy in the UK","volume":"28","author":"Cooper","year":"2020","journal-title":"Int J Pharm Pract"},{"key":"2025121510063367000_11.6.e050043.77","doi-asserted-by":"crossref","unstructured":"Robinson J . Health professionals delivering unlicensed vaccines need government protection, say health bodies. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208381","DOI":"10.1211\/PJ.2020.20208381"},{"key":"2025121510063367000_11.6.e050043.78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ijpp.12037","article-title":"Increasing seasonal influenza vaccination uptake using community pharmacies: experience from the Isle of Wight, England","volume":"21","author":"Warner","year":"2013","journal-title":"Int J Pharm Pract"},{"key":"2025121510063367000_11.6.e050043.79","unstructured":"Voice P , The Pharmaceutical Services Negotiating Committee, The Royal Pharmaceutical Society . Consultation response: UK influenza pandemic preparedness strategy 2011 2011."},{"key":"2025121510063367000_11.6.e050043.80","doi-asserted-by":"crossref","DOI":"10.1002\/jac5.1246","article-title":"Hero clinical pharmacists and the COVID-19 pandemic: Overworked and overlooked","author":"Bauman","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"2025121510063367000_11.6.e050043.81","doi-asserted-by":"crossref","DOI":"10.5688\/ajpe8146","article-title":"The impact of COVID-19 through the eyes of a Fourth-Year pharmacy student","volume":"84","author":"Stone","year":"2020","journal-title":"Am J Pharm Educ"},{"key":"2025121510063367000_11.6.e050043.82","unstructured":"Royal College of General Practitioners . Delivering mass vaccinations during COVID-19 a logistical guide for general practice. London: Royal College of General Practitioners, 2020. https:\/\/www.lmc.org.uk\/visageimages\/Covid-19\/RCGPMassVaccinationattimeofcovidV3.1.pdf"},{"key":"2025121510063367000_11.6.e050043.83","doi-asserted-by":"crossref","first-page":"2002-2004","DOI":"10.1016\/j.sapharm.2020.07.001","article-title":"Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies","volume":"17","author":"Koster","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.84","doi-asserted-by":"crossref","unstructured":"Bukhari N , Rasheed H , Nayyer B , et al . Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract 2020;13.doi:10.1186\/s40545-020-00210-w","DOI":"10.1186\/s40545-020-00210-w"},{"key":"2025121510063367000_11.6.e050043.85","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1715163520930191","article-title":"Pharmacists on the frontline","volume":"153","author":"Eidt","year":"2020","journal-title":"Can Pharm J"},{"key":"2025121510063367000_11.6.e050043.86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1715163520930705","article-title":"Pharmacists step up to the challenge of COVID-19","volume":"153","author":"Farrell","year":"2020","journal-title":"Can Pharm J"},{"key":"2025121510063367000_11.6.e050043.87","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/pharmacy8030140","article-title":"The role of hospital and community pharmacists in the management of COVID-19: towards an expanded definition of the roles, responsibilities, and duties of the pharmacist","volume":"8","author":"Bragazzi","year":"2020","journal-title":"Pharmacy"},{"key":"2025121510063367000_11.6.e050043.88","doi-asserted-by":"crossref","unstructured":"Chan AHY , Rutter V , Ashiru-Oredope D , et al . Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic. J Pharm Policy Pract 2020;13.doi:10.1186\/s40545-020-00214-6","DOI":"10.1186\/s40545-020-00214-6"},{"key":"2025121510063367000_11.6.e050043.89","doi-asserted-by":"crossref","unstructured":"Moore A . Pharmacists in one county say working with GP practices during the COVID-19 pandemic has been \u2018difficult\u2019. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208556","DOI":"10.1211\/PJ.2020.20208556"},{"key":"2025121510063367000_11.6.e050043.90","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11096-020-01078-1","article-title":"Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information","volume":"42","author":"Hoti","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"2025121510063367000_11.6.e050043.91","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4140\/TCP.n.2020.286","article-title":"The role of pharmacists in the fight against COVID-19","volume":"35","author":"Chahine","year":"2020","journal-title":"Sr Care Pharm"},{"key":"2025121510063367000_11.6.e050043.92","unstructured":"Jubraj B . Remote consultations: how pharmacy teams can practise them successfully: pharmaceutical-journal.com, 2020. Available: https:\/\/pharmaceutical-journal.com\/article\/ld\/remote-consultations-how-pharmacy-teams-can-practise-them-successfully"},{"key":"2025121510063367000_11.6.e050043.93","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ijpp.12419","article-title":"Community pharmacists\u2019 opinions on skill-mix and delegation in England","volume":"26","author":"Barnes","year":"2018","journal-title":"Int J Pharm Pract"},{"key":"2025121510063367000_11.6.e050043.94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1715163514536678","article-title":"Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services","volume":"147","author":"Houle","year":"2014","journal-title":"Can Pharm J"},{"key":"2025121510063367000_11.6.e050043.95","doi-asserted-by":"crossref","unstructured":"Burns C . Pharmacy staff in Scotland to receive \u00a3500 bonus in recognition of COVID-19 service. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208614","DOI":"10.1211\/PJ.2020.20208614"},{"key":"2025121510063367000_11.6.e050043.96","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.sapharm.2020.05.033","article-title":"The legal extension of the role of pharmacists in light of the COVID-19 global pandemic","volume":"17","author":"Merks","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.97","doi-asserted-by":"crossref","first-page":"1832-1837","DOI":"10.1016\/j.sapharm.2020.07.006","article-title":"Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: results from a national survey","volume":"17","author":"Zaidi","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.98","doi-asserted-by":"crossref","unstructured":"Anon . Pharmacies must be at the forefront of the COVID-19 vaccination campaign. The Pharmaceutical Journal 2020;305.doi:10.1211\/PJ.2020.20208546","DOI":"10.1211\/PJ.2020.20208546"},{"key":"2025121510063367000_11.6.e050043.99","doi-asserted-by":"crossref","unstructured":"Robinson J . England has lowest number of community pharmacies in five years, figures show. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208569","DOI":"10.1211\/PJ.2020.20208569"},{"key":"2025121510063367000_11.6.e050043.100","doi-asserted-by":"crossref","unstructured":"Wickware C . Pharmacies to be paid 50p more per flu vaccination in 2020\/2021. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208362","DOI":"10.1211\/PJ.2020.20208362"},{"key":"2025121510063367000_11.6.e050043.101","unstructured":"Doyle-Price J . Pharmacies have an important role in this pandemic \u2013 but they need help to continue saving lives. The Telegraph, 2020. Available: https:\/\/www.telegraph.co.uk\/global-health\/science-and-disease\/pharmacies-have-crucial-place-communities-need-help-continue"},{"key":"2025121510063367000_11.6.e050043.102","doi-asserted-by":"crossref","unstructured":"Robinson J . Up to 85% of community pharmacies could be in financial deficit by 2024, economic analysis concludes. The Pharmaceutical Journal 2020.doi:10.1211\/PJ.2020.20208332","DOI":"10.1211\/PJ.2020.20208332"},{"key":"2025121510063367000_11.6.e050043.103","doi-asserted-by":"crossref","unstructured":"Wilkinson E , Connelly D . Is pharmacy prepared for a resurgence of COVID-19? The Pharmaceutical Journal 2020;305.doi:10.1211\/PJ.2020.20208340","DOI":"10.1211\/PJ.2020.20208340"},{"key":"2025121510063367000_11.6.e050043.104","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2020.52"},{"key":"2025121510063367000_11.6.e050043.105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/pharmacy8030128","article-title":"Choosing evolution over extinction: integrating direct patient care services and value-based payment models into the community-based pharmacy setting","volume":"8","author":"Mercadante","year":"2020","journal-title":"Pharmacy"},{"key":"2025121510063367000_11.6.e050043.106","doi-asserted-by":"crossref","unstructured":"Broughel J , Yatsyshina Y . Relax pharmacy regulations to help with COVID-19 testing and treatment. SSRN Electronic Journal 2020.doi:10.2139\/ssrn.3564463","DOI":"10.2139\/ssrn.3564463"},{"key":"2025121510063367000_11.6.e050043.107","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.japh.2020.06.004","article-title":"Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic","volume":"60","author":"Pritchard","year":"2020","journal-title":"J Am Pharm Assoc"},{"key":"2025121510063367000_11.6.e050043.108","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.sapharm.2020.07.037","article-title":"COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic","volume":"17","author":"Lynch","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.109","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.sapharm.2020.04.032","article-title":"When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19","volume":"17","author":"Erku","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.110","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ajhp\/zxaa291","article-title":"Improving patient care and demonstrating value during a global pandemic: recommendations from leaders of the pharmacy accountability measures work group","volume":"77","author":"Andrawis","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"2025121510063367000_11.6.e050043.111","doi-asserted-by":"crossref","DOI":"10.5688\/ajpe8197","article-title":"COVID-19 pandemic challenges and lessons learned by pharmacy educators around the globe","volume":"84","author":"Kawaguchi-Suzuki","year":"2020","journal-title":"Am J Pharm Educ"},{"key":"2025121510063367000_11.6.e050043.112","unstructured":"General Pharmaceutical Council . Rising to the challenge [blog], 2020. Available: https:\/\/www.pharmacyregulation.org\/regulate\/blog\/rising-challenge"},{"key":"2025121510063367000_11.6.e050043.113","unstructured":"Nessel J . Pharmacy technicians rise to meet patient needs during coronavirus pandemic. Pharmacy Times, 2020. Available: https:\/\/www.pharmacytimes.com\/view\/pharmacy-technicians-rise-to-meet-patient-needs-during-coronavirus-pandemic"},{"key":"2025121510063367000_11.6.e050043.114","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/08897077.2020.1752351","article-title":"Opioid use disorder and the COVID 19 pandemic: a call to sustain regulatory easements and further expand access to treatment","volume":"41","author":"Green","year":"2020","journal-title":"Substance Abuse"},{"key":"2025121510063367000_11.6.e050043.115","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.08.009"},{"key":"2025121510063367000_11.6.e050043.116","first-page":"9","article-title":"The effect of the new community pharmacy contract on the community pharmacy workforce","volume":"8","author":"Bond","year":"2008","journal-title":"London: Pharmacy Practice Research Trust"},{"key":"2025121510063367000_11.6.e050043.117","doi-asserted-by":"publisher","DOI":"10.2147\/IPRP.S107612"},{"key":"2025121510063367000_11.6.e050043.118","doi-asserted-by":"crossref","first-page":"169-171","DOI":"10.1111\/jrh.12438","article-title":"A primary care response to COVID-19 for patients with an opioid use disorder","volume":"37","author":"Wilson","year":"2021","journal-title":"J Rural Health"},{"key":"2025121510063367000_11.6.e050043.119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpsychires.2020.07.005","article-title":"Panic buying or good adherence? increased pharmacy purchases of drugs from wholesalers in the last week prior to Covid-19 lockdown","volume":"130","author":"Kostev","year":"2020","journal-title":"J Psychiatr Res"},{"key":"2025121510063367000_11.6.e050043.120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.31128\/AJGP-04-20-5390","article-title":"Strategies to promote access to medications during the COVID-19 pandemic","volume":"49","author":"Bell","year":"2020","journal-title":"Aust J Gen Pract"},{"key":"2025121510063367000_11.6.e050043.121","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.sapharm.2020.05.024","article-title":"Time-Trend analysis of medicine sales and shortages during COVID-19 outbreak: data from community pharmacies","volume":"17","author":"Romano","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.122","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jac5.1231","article-title":"Roles of the clinical pharmacist during the COVID-19 pandemic","volume":"3","author":"Gross","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"2025121510063367000_11.6.e050043.123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.therap.2020.06.006","article-title":"Addictovigilance contribution during COVID-19 epidemic and lockdown in France","volume":"75","author":"Lapeyre-Mestre","year":"2020","journal-title":"Therapies"},{"key":"2025121510063367000_11.6.e050043.124","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2020.146"},{"key":"2025121510063367000_11.6.e050043.125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.sapharm.2020.04.033","article-title":"Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures?","volume":"17","author":"Hasan","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.126","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010851"},{"key":"2025121510063367000_11.6.e050043.127","unstructured":"NHS England and NHS Improvement coronavirus . Standard operating procedure: COVID-19 local vaccination services deployment in community settings. London: National Health Service, 2020. https:\/\/www.england.nhs.uk\/coronavirus\/publication\/standard-operating-procedure-covid-19-local-vaccination-services-deployment-in-community-settings"},{"key":"2025121510063367000_11.6.e050043.128","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.sapharm.2020.05.020","article-title":"Community pharmacists' exposure to COVID-19","volume":"17","author":"Cabas","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.sapharm.2020.03.018","article-title":"SARS-CoV-2 outbreak: how can pharmacists help?","volume":"17","author":"Al-Quteimat","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.130","doi-asserted-by":"crossref","first-page":"1950-1953","DOI":"10.1016\/j.sapharm.2020.05.011","article-title":"Emerging from the other end: key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists","volume":"17","author":"Dawoud","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2019.08.029"},{"key":"2025121510063367000_11.6.e050043.132","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe8155"},{"key":"2025121510063367000_11.6.e050043.133","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/psb.1844","article-title":"Will serious shortage protocols help ease drug shortages?","volume":"31","author":"Dowden","year":"2020","journal-title":"Prescriber"},{"key":"2025121510063367000_11.6.e050043.134","unstructured":"NHS England, NHS Improvement coronavirus . Novel coronavirus (COVID-19) standard operating procedure-Community pharmacy, 2020. Available: https:\/\/www.england. nhs. uk\/wp-content\/uploads\/2020\/02\/20200305-COVID-19-PRIMARY-CARE-SOP-COMM-PHARM-PUBLICATION-V1"},{"key":"2025121510063367000_11.6.e050043.135","unstructured":"National Pharmacy Association (NPA) . Pharmacy on the NHS frontline 2020, 2020. Available: https:\/\/nhsfrontline.com\/coronavirus-stories-from-the-health-service-frontline [Accessed 17\/08\/2020]."},{"key":"2025121510063367000_11.6.e050043.136","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1016\/j.japh.2017.02.010","article-title":"The impact of an immunization check-up at a pharmacist-provided employee health screening","volume":"57","author":"Sparkman","year":"2017","journal-title":"J Am Pharm Assoc"},{"key":"2025121510063367000_11.6.e050043.137","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S112931"},{"key":"2025121510063367000_11.6.e050043.138","doi-asserted-by":"crossref","unstructured":"Letley L , Ramsay M . Discussing the MMR vaccine with patients. The Pharmaceutical Journal 2019.doi:10.1211\/PJ.2019.20205819","DOI":"10.1211\/PJ.2019.20205819"},{"key":"2025121510063367000_11.6.e050043.139","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ijpp.12375","article-title":"The public\u2019s perception of the role of community pharmacists in Wales","volume":"26","author":"Kember","year":"2018","journal-title":"Int J Pharm Pract"},{"key":"2025121510063367000_11.6.e050043.140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-000939","article-title":"Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study","volume":"2","author":"Gidman","year":"2012","journal-title":"BMJ Open"},{"key":"2025121510063367000_11.6.e050043.141","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/j.vaccine.2016.04.076","article-title":"A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health","volume":"34","author":"McConeghy","year":"2016","journal-title":"Vaccine"},{"key":"2025121510063367000_11.6.e050043.142","first-page":"860","article-title":"COVID-19 and clinical pharmacy worldwide - a wake up call and a call to action","volume":"3","author":"Cheong","year":"2020","journal-title":"JACCP JAm Coll Clin Pharm"},{"key":"2025121510063367000_11.6.e050043.143","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.sapharm.2020.04.002","article-title":"Pharmacy emergency preparedness and response (pepR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond","volume":"17","author":"Aruru","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025121510063367000_11.6.e050043.144","doi-asserted-by":"crossref","unstructured":"Robinson J . Public health England to review guidance against the use of rapid COVID-19 tests in community pharmacies. The Pharmaceutical Journal 2020;305.doi:10.1211\/PJ.2020.20208550","DOI":"10.1211\/PJ.2020.20208550"},{"key":"2025121510063367000_11.6.e050043.145","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.151027"},{"key":"2025121510063367000_11.6.e050043.146","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1080\/21645515.2019.1602433","article-title":"Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states","volume":"15","author":"Calo","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2025121510063367000_11.6.e050043.147","doi-asserted-by":"crossref","unstructured":"Anderson C , Thornley T . \u201cIt\u2019s easier in pharmacy\u201d: why some patients prefer to pay for flu jabs rather than use the National Health Service. BMC Health Serv Res 2014;14.doi:10.1186\/1472-6963-14-35","DOI":"10.1186\/1472-6963-14-35"},{"key":"2025121510063367000_11.6.e050043.148","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.03.006"},{"key":"2025121510063367000_11.6.e050043.149","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11096-016-0255-z","article-title":"Who uses pharmacy for flu vaccinations? population profiling through a UK pharmacy chain","volume":"38","author":"Anderson","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"2025121510063367000_11.6.e050043.150","unstructured":"Pharmacy Guild of Australia . 93 per cent of Aussies recognise benefits of flu shot in pharmacy\u2013Pharmacy Guild of Australia [blog]: Pharmacy Guild of Australia 2017, 2017. Available: https:\/\/www.guild.org.au\/news-events\/news\/2017\/93-per-cent-of-aussies-recognise-benefits-of-flu-shot-in-pharmacy"},{"key":"2025121510063367000_11.6.e050043.151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/pharmacy6010013","article-title":"Giving voice to the medically Under-Served: a qualitative Co-Production approach to explore patient medicine experiences and improve services to Marginalized communities","volume":"6","author":"Latif","year":"2018","journal-title":"Pharmacy"},{"key":"2025121510063367000_11.6.e050043.152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2004.00274.x"},{"key":"2025121510063367000_11.6.e050043.153","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-582"},{"key":"2025121510063367000_11.6.e050043.154","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2524.2000.00222.x"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-050043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:06:51Z","timestamp":1765822011000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-050043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":154,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,16]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/bmjopen-2021-050043"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-050043","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.01.21250765","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}